SMS Lifesciences India Limited Total Liabilities

Latest as of September 2025: Rs1.71 Billion INR ≈ $18.54 Million USD

SMS Lifesciences India Limited total liabilities. Based on the latest financial reports, SMS Lifesciences India Limited (SMSLIFE) has total liabilities worth Rs1.71 Billion INR (≈ $18.54 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SMSLIFE financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of SMS Lifesciences India Limited (2016–2025)

Total liabilities of SMS Lifesciences India Limited from 2016 to 2025. This chart illustrates how SMS Lifesciences India Limited's total liabilities have evolved over time, based on quarterly financial data. Explore SMS Lifesciences India Limited (SMSLIFE) investment intensity to see how much of total assets are deployed in long-term investments.

SMS Lifesciences India Limited Competitors by Total Liabilities

The table below lists competitors of SMS Lifesciences India Limited ranked by their total liabilities.

Company Country Total Liabilities
Sunzen Biotech Bhd
KLSE:0148
Malaysia RM18.73 Million
Better Life Group Co Ltd
TW:1805
Taiwan NT$369.27 Million
Eversendai Corporation Bhd
KLSE:5205
Malaysia RM2.28 Billion
Cryosite Ltd
AU:CTE
Australia AU$22.94 Million
Exel Composites Oyj
HE:EXL1V
Finland €61.14 Million
Workpoint Entertainment Public Company Limited
BK:WORK
Thailand ฿638.71 Million
Rama Phosphates Limited
NSE:RAMAPHO
India Rs-4.22 Billion
CVRx Inc
NASDAQ:CVRX
USA $72.33 Million

Liability Composition Analysis (2016–2025)

This chart breaks down SMS Lifesciences India Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SMSLIFE total asset value.

Liquidity & Leverage Metrics

SMS Lifesciences India Limited Total Liabilities Ratios Explained

SMS Lifesciences India Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.06 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.83 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.44 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SMS Lifesciences India Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SMS Lifesciences India Limited (2016–2025)

The table below shows the annual total liabilities of SMS Lifesciences India Limited from 2016 to 2025.

Year Total Liabilities Change
2025-03-31 Rs1.78 Billion
≈ $19.24 Million
-9.62%
2024-03-31 Rs1.97 Billion
≈ $21.29 Million
+13.57%
2023-03-31 Rs1.73 Billion
≈ $18.75 Million
-9.62%
2022-03-31 Rs1.92 Billion
≈ $20.74 Million
+10.83%
2021-03-31 Rs1.73 Billion
≈ $18.72 Million
+26.25%
2020-03-31 Rs1.37 Billion
≈ $14.83 Million
-16.21%
2019-03-31 Rs1.64 Billion
≈ $17.70 Million
+85.41%
2018-03-31 Rs882.47 Million
≈ $9.54 Million
-8.06%
2017-03-31 Rs959.82 Million
≈ $10.38 Million
-7.01%
2016-03-31 Rs1.03 Billion
≈ $11.16 Million
--

About SMS Lifesciences India Limited

NSE:SMSLIFE India Biotechnology
Market Cap
$42.13 Million
Rs3.90 Billion INR
Market Cap Rank
#22332 Global
#1226 in India
Share Price
Rs1288.50
Change (1 day)
-6.64%
52-Week Range
Rs1150.70 - Rs1437.90
All Time High
Rs1747.88
About

Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, a… Read more